Ivan Jambor1, Peter Boström2, Pekka Taimen1, Esa Kähkönen2, Markku Kallajoki2, Tommi Kauko1, Ileana Montoya1, Otto Ettala2, Harri Merisaari1, Kari Syvänen2, and Hannu Juhani Aronen1
this prospective single institution registered clinical trial we aimed to
evaluate the role of rapid pre-biopsy prostate MRI consisting of T2-weighted
imaging and DWI, no endorectal coil, no iv contrast. The primary end point was
the diagnostic accuracy of the models incorporating clinical variables, PSA,
and MRI findings. In total 175 patients were enrolled and 161 were included in
final analyses. Rapid pre-biopsy prostate MRI was shown to be an accurate tool
for the management of patients with a clinical suspicion of prostate cancer.